Aprea Therapeutics, Inc.
APRE
$0.79
-$0.04-4.97%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 41.23M | 46.47M | 14.60M | 13.72M | 16.53M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 679.70K | 779.20K | 961.90K | 225.90K | 395.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 41.91M | 47.25M | 15.56M | 13.94M | 16.93M |
|
|
|||||
| Total Current Assets | 41.91M | 47.25M | 15.56M | 13.94M | 16.93M |
| Net Property, Plant & Equipment | 64.00K | 54.40K | 59.80K | 65.20K | 70.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 312.80K | 312.60K | 312.30K | 312.10K | 311.80K |
| Total Assets | 42.29M | 47.61M | 15.93M | 14.32M | 17.31M |
|
|
|||||
| Total Accounts Payable | 935.10K | 2.94M | 713.70K | 641.30K | 1.20M |
| Total Accrued Expenses | 2.16M | 2.36M | 2.05M | 2.04M | 1.97M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.09M | 5.30M | 2.76M | 2.68M | 3.17M |
|
|
|||||
| Total Current Liabilities | 3.09M | 5.30M | 2.76M | 2.68M | 3.17M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.09M | 5.30M | 2.76M | 2.68M | 3.17M |
|
|
|||||
| Common Stock & APIC | 389.61M | 389.64M | 356.72M | 352.73M | 352.26M |
| Retained Earnings | -340.52M | -336.93M | -333.64M | -331.19M | -328.21M |
| Treasury Stock & Other | -10.62M | -11.13M | -10.63M | -10.63M | -10.63M |
| Total Common Equity | 38.47M | 41.59M | 12.44M | 10.91M | 13.41M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 727.40K | 727.40K | 727.40K | 727.40K | 727.40K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 727.40K | 727.40K | 727.40K | 727.40K | 727.40K |
|
|
|||||
| Total Common Equity | 38.47M | 41.59M | 12.44M | 10.91M | 13.41M |
| Total Preferred Equity | 727.40K | 727.40K | 727.40K | 727.40K | 727.40K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 39.20M | 42.32M | 13.17M | 11.64M | 14.14M |
|
|
|||||